These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 29107091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using 18F-FDG-PET.
    Li XY, Men WW, Zhu H, Lei JF, Zuo FX, Wang ZJ, Zhu ZH, Bao XJ, Wang RZ.
    Int J Mol Sci; 2016 Oct 18; 17(10):. PubMed ID: 27763550
    [Abstract] [Full Text] [Related]

  • 3. Telomere length and micronuclei trajectories in APP/PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner.
    Guo X, Li J, Qi Y, Chen J, Jiang M, Zhu L, Liu Z, Wang H, Wang G, Wang X.
    Aging Cell; 2024 May 18; 23(5):e14121. PubMed ID: 38450924
    [Abstract] [Full Text] [Related]

  • 4. Tissue-Specific Metabolomics Analysis Identifies the Liver as a Major Organ of Metabolic Disorders in Amyloid Precursor Protein/Presenilin 1 Mice of Alzheimer's Disease.
    Zheng H, Cai A, Shu Q, Niu Y, Xu P, Li C, Lin L, Gao H.
    J Proteome Res; 2019 Mar 01; 18(3):1218-1227. PubMed ID: 30592618
    [Abstract] [Full Text] [Related]

  • 5. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY.
    Behav Brain Res; 2010 Jul 29; 211(1):125-31. PubMed ID: 20307581
    [Abstract] [Full Text] [Related]

  • 6. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R, García-Barrera T, Vitorica J, Gómez-Ariza JL.
    Biochim Biophys Acta; 2014 Dec 29; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K, Zhao H, Shen H, Wang Z, Gao X, Zhao W, Yin M.
    Neurosci Lett; 2013 Dec 17; 557 Pt B():84-9. PubMed ID: 24176881
    [Abstract] [Full Text] [Related]

  • 9. Metabolic fate of glucose in the brain of APP/PS1 transgenic mice at 10 months of age: a 13C NMR metabolomic study.
    Zhou Q, Zheng H, Chen J, Li C, Du Y, Xia H, Gao H.
    Metab Brain Dis; 2018 Oct 17; 33(5):1661-1668. PubMed ID: 29946959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
    Puig KL, Kulas JA, Franklin W, Rakoczy SG, Taglialatela G, Brown-Borg HM, Combs CK.
    Neurobiol Aging; 2016 Apr 17; 40():22-40. PubMed ID: 26973101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP/PS1 Double Transgenic AD Mice by Regulating Keap1/Nrf2/HO-1 Pathway to Improve Cognitive Impairment.
    Cheng M, Yuan C, Ju Y, Liu Y, Shi B, Yang Y, Jin S, He X, Zhang L, Min D.
    Behav Neurol; 2024 Apr 17; 2024():5698119. PubMed ID: 39233848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G, Rivest S.
    J Neurosci; 2011 Apr 20; 31(16):6208-20. PubMed ID: 21508244
    [Abstract] [Full Text] [Related]

  • 17. [Reproduction,genotype identification and evaluation of APP/PS1 transgenic mice].
    Tan L, Li HQ, Li YB, Liu W, Pang W, Jiang YG.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb 08; 34(2):111-114. PubMed ID: 29926672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL, Wong LR, Pee HN, Yang S, Ho PC.
    Mol Neurobiol; 2019 Nov 08; 56(11):7267-7283. PubMed ID: 31016475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.